← SynDRA
HALOPERIDOL
SynDRA canonical compound SYN0000269 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | HTR2A |
|---|
| Mechanism of action | Dopamine receptor antagonist |
|---|
| Indication | schizophrenia | Tourette's disorder |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
- DRD2
- DRD3
- DRD4
- HTR2A
- DRD1
- HTR1A
- HTR7
- DRD5
- KCNH1
- HTR2B
- HRH1
- HTR1D
Mechanisms of action (all sources)
- Dopamine receptor antagonist
- HTR2A ANTAGONIST
- Serotonin 2a (5-HT2a) receptor antagonist
- DRD2 INVERSE AGONIST
- D2-like dopamine receptor inverse agonist
- DRD3 INVERSE AGONIST
- DRD4 INVERSE AGONIST
- HTR1A ANTAGONIST
- HTR1D ANTAGONIST
- HTR2B ANTAGONIST
- HTR7 ANTAGONIST
- DRD1 ANTAGONIST
Drug classes
- Anti-Dyskinesia Agents
- Antiemetics
- Antipsychotic Agents
- Central Nervous System Agents
- Central Nervous System Depressants
- Dopamine Agents
- Dopamine Antagonists
- Gastrointestinal Agents
- Neurotransmitter Agents
- Peripheral Nervous System Agents
- Psychotropic Drugs
- Tranquilizing Agents
ATC classes
Cross-references
Synonyms
- aloperidin
- haloperin
- sigaperidol
- haloperidol lactate
- MCN-JR-1625
- NSC-170973
- NSC-615296
- R-1625
- Dolpin
- Dozic
- Fortunan
- Haldol
- Haldol solutab
- Haloperidol component of vesalium
- Kentace
- Keselen
- Serenace
- Haloperidol decanoate impurity, haloperidol-
- Aldo
- Aloperidin
- Aloperidol
- Aloperidolo
- Aloperidon
- Bioperidolo
- Brotopon
- Dozix
- Eukystol
- Galoperidol
- Halidol
- Halojust
- Halol
- Halopal
- Haloperido
- Haloperidolum
- Halopidol
- Halopoidol
- Halosten
- Keselan
Reported adverse events
- Dystonia
- Agranulocytosis
- Neuroleptic malignant syndrome
- Tachycardia
- Tardive dyskinesia
- Insomnia
- Dyskinesia
- Dry mouth
- Laryngospasm
- Cataract
- Akinesia
- Jaundice
Look up HALOPERIDOL in the interactive SynDRA portal →